InterCure Stock to Reverse Split on Monday, August 24th (NASDAQ:INCR)

Shares of InterCure Ltd. (NASDAQ:INCR) are scheduled to reverse split on the morning of Monday, August 24th. The 1-5 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, August 23rd.

InterCure Stock Down 2.1%

Shares of InterCure stock opened at $0.93 on Thursday. The business has a 50-day moving average of $0.97 and a 200-day moving average of $0.89. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.48 and a quick ratio of 0.97. The company has a market capitalization of $50.85 million, a PE ratio of 31.00 and a beta of 1.40. InterCure has a 1-year low of $0.68 and a 1-year high of $1.71.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised InterCure from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, July 9th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

InterCure Company Profile

InterCure Ltd is an Israel-based medical cannabis company publicly listed on the Nasdaq Capital Market under the ticker INCR. The company’s operations span the entire value chain of medical cannabis, from the development of proprietary seed strains and controlled cultivation in a GMP-compliant facility to laboratory testing, cannabinoid extraction and formulation. InterCure serves licensed pharmacies and clinics within Israel and adheres to the regulatory framework established by the Israeli Ministry of Health.

Founded in 2013, InterCure has built a vertically integrated platform that supports both patient care and research initiatives.